HOME >> BIOLOGY >> NEWS
Power plants, other industry could offer contracts to farmers in helping reduce carbon emissions

COLLEGE STATION Two research economists say electrical power plants and other manufacturing agencies could someday seek the aid of farmers, offering contracts to help industrial firms reduce carbon emissions. For farmers, such agreements could create an additional source of income and make carbon a traded commodity.

Dr. Bruce McCarl, a Texas Agricultural Experiment Station economist, and Dr. Tanveer Butt, a professor of economics at Texas A&M University, are looking at the possibilities.

The researchers said global warming is partially due to an increase in greenhouse gases, and is released primarily by power plants, automobiles, manufacturing companies and tropical deforestation.

Both McCarl and Butt said carbon dioxide is the most dominant greenhouse gas. Since crops and trees process carbon dioxide and return it back into the soil in the form of carbon, land used by agriculture could play an important role in carbon sequestration.

Land management practices, such as tree production, the planting of grasses on rangeland, and conservation tillage, are a few methods that would help reduce levels of carbon dioxide.

"Plants can take carbon from the air and put it back into the soil, and this could be a cheaper alternative than causing cutbacks or technology change in the energy or manufacturing industries," Butt explained

Agriculture could play a key role in carbon reduction when industry, such as power plants, might face greenhouse gas emission limits and look for ways to offset levels that are above the limits.

The major sources of greenhouse gas emissions in the United States are power plants (36 percent), transportation (28 percent) and the manufacturing industry (22 percent), according to the U.S. Environmental Protection Agency.

There are two fundamental ways that farmers might be paid for sequestration. A subsidy program might pay farmers to retire land or alter practices. The second altern
'"/>

Contact: Dr. Tanveer Butt
TBUTT@ag.tamu.edu
979-845-3805
Texas A&M University - Agricultural Communications
3-Mar-2004


Page: 1 2 3

Related biology news :

1. Powerful machines are coming in small packages
2. Powerful new method helps reveal genetic basis of cancer
3. Powered by your liquor cabinet, biofuel cell could replace rechargeable batteries
4. Powerful technologies probe innate immunity
5. UC Irvine Advanced Power and Energy Program awarded $3 million grant by California Energy Commission
6. Powering the seafloor
7. Powerful Anti-AIDS Agent Found In Tears And In Urine Of Pregnant Women
8. Team Solves X-ray Structure Of Powerful Enzyme
9. New Biomaterial Has Star Power
10. Photosynthetic Harvest Inc. Harnesses The Power Of Natures Chemical Factories By "Milking" Green Plants For Valuable Natural Products
11. Synthetic Vitamin E And Natural Vitamin E Are Equally Powerful Antioxidents

Post Your Comments:
(Date:5/7/2015)... , May 7, 2015 ... sensors, FPC1022 and FPC1035, FPC,s smallest touch fingerprint ... are mainly considered for integration on the backside ... smartphone OEMs increased possibilities to integrate touch fingerprint ... size also improves possibilities for module manufacturers to ...
(Date:4/27/2015)... Profile Solutions, Inc. (OTC: PSIQ), a leading ... pleased to announce that Dr Gerry Bedore ... of its scientific advisory board. ... leader in technology-enhanced learning models. He was a co-founder ... studies and books focused on online student success and ...
(Date:4/14/2015)... , April 14, 2015  HYPR Corp. ... Online (FIDO ® ) Alliance tm , an ... FIDO members commit to share technology and collaborate ... that are interoperable, more secure and private, and ... biometric identity verification that protects sensitive user information ...
Breaking Biology News(10 mins):FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3
(Date:5/21/2015)... NOVATO, Calif. , May 21, 2015 /PRNewswire-USNewswire/ ... Orrin Hatch (R-UT) and Amy ... Product Extensions Now Accelerating Cures & Treatments, or ... 150 rare disease patient advocacy organizations, this bipartisan ... effective, and affordable medicines to rare disease patients ...
(Date:5/21/2015)... W. R. Grace & Co. ... Worms, Germany has received good manufacturing practice (GMP) ... International Pharmaceutical Excipient Council (IPEC) Foundation. ... SYLOID® FP brand of pharmaceutical grade excipient silica ... Curtis Bay, Maryland (USA) and Sorocaba, Brazil locations. ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
(Date:5/21/2015)... Research and Markets ( http://www.researchandmarkets.com/research/84975r/2015_global ... "2015 Global Survey on Flow Cytometry Adoption Trends" ... primary goal of this research is to analyze ... Key information the survey seeks to collect include ... predominantly used applications for flow cytometers, respondents, most ...
Breaking Biology Technology:Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Global Survey on Flow Cytometry Adoption Trends 2015 2
Cached News: